GlaxoSmithKline’s Herpes Vaccine Fails in Trial, US National Institutes of Health (NIH) Says

September 30, 2010 |

1 min read

Twitter
LinkedIn
Facebook
Email
Print

WASHINGTON, Sept 30 (Reuters) - GlaxoSmithKline (GSK.L) (GSK.N) said on Thursday that it was stopping development of a genital herpes vaccine after it failed to protect women against the virus.

Twitter
LinkedIn
Facebook
Email
Print

Clinical research Phase III

GlaxoSmithKline